Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Physio-Control receives US FDA clearance to market LIFEPAK 20e defibrillator/monitor

Medtronic : 03 October, 2008  (New Product)
Physio-Control, a wholly owned subsidiary of Medtronic has received clearance by the US Food and Drug Administration to market the LIFEPAK 20e defibrillator/monitor within the USA.
The 20e is an enhancement of the LIFEPAK 20 defibrillator/monitor, which has become the standard of care in many hospitals worldwide since its introduction in 2002. The device offers all the capabilities of the LIFEPAK 20 device, along with a more powerful Lithium-ion battery that doubles ECG monitoring time and the run time of other parameters such as non-invasive pacing and pulse oximetry, a noninvasive way to monitor the oxygenation of a patient’s haemoglobin. Additionally, a new on‑screen 'fuel gauge' displays the real-time status of available battery capacity so clinicians can monitor remaining use time.

The 20e also was developed to be easily transported, helping hospitals meet the Joint Commission for Accreditation of Healthcare Organizations (JCAHO) standard for having resuscitation services readily available in all facility areas.

“We are very pleased to have received 510(k) clearance from the FDA on the LIFEPAK 20e defibrillator/monitor. Physio‑Control has a long history of providing products for the hospital marketplace and the 20e will fit well into the line of reliable, quality products customers have come to expect from us,” said Brian Webster, president of Physio-Control.

“It is an exciting time for our company as we continue to provide our customers with new generations of LIFEPAK products.”

Physio‑Control is currently under a consent decree with the FDA, which restricts the amount of products that can be delivered to customers until certain improvements in the company’s quality system have been completed. However, the company is permitted to manufacture and ship a limited selection of product under certain conditions to meet the critical needs of emergency response customers.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo